APEIRON Biologics AG is a European private biotechnology company based in Vienna that specializes in the discovery, development and commercialization of novel immunotherapies for cancer and respiratory diseases. APEIRON’s APN01/alunacadase alfa (rhsACE2) is undergoing a Phase II clinical trial for the treatment of Covid-19. APEIRON has an approved product on the market, Qarziba® for the treatment of pediatric neuroblastoma patients which is distributed by EUSA Pharma Ltd. APEIRON's clinical program APN401 is a first-in-class autologous cell therapy to strengthen immune reactivity via targeting the intra-cellular master checkpoint, Cbl-b. APEIRON’s project and technologies are based on a strong patent portfolio and partnerships with leading pharmaceutical companies and academic institutions.
Project Manager for Pharmaceutical Development
To strengthen our development activities for our main office in Vienna we are looking for a committed and independent Project Manager with a strong regulatory background.
For the position we offer at least an annual gross salary of EUR 65.000,-. The actual remuneration package will be based on your professional experience, qualification and skills. Increased pay is possible
If you enjoy working in a motivated team with an open and friendly corporate culture we are looking forward to receiving your application (incl. cover letter and curriculum vitæ with photo). Please note that we will focus our interview process based on a willingness to work in Vienna.
Contact: Head of HR, Elena Pretterebner
APEIRON Biologics AG, Campus-Vienna-Biocenter 5, 1030 Vienna
Informationen zum Umgang mit Ihren personenbezogenen Daten finden Sie hier: https://www.apeiron-biologics.com/privacy-policy/